Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks

Group 1 - Kenvue Inc. (NYSE:KVUE) is recognized as one of the 10 Best NYSE Dividend Stocks to Buy, highlighting its strong position in the market [1] - The company produces and sells a variety of consumer health products, including over-the-counter medicines, personal care, and wellness items, featuring well-known brands like Tylenol, Neutrogena, and Listerine [2] - Following its separation from Johnson & Johnson in 2023, Kenvue has focused on enhancing brand relevance through digital tools and consumer insights, while also modernizing its supply chain and ensuring regulatory compliance [3] Group 2 - Kenvue has been designated as a Dividend King, offering a quarterly dividend of $0.2075 per share, which was increased by 1.2% in July, resulting in a dividend yield of 4.53% as of September 20 [4]